Annual report pursuant to Section 13 and 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.22.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Schedule of Cash, Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the balance sheets to the same amounts shown in the statement of cash flows as of December 31, 2021 and 2020 (in thousands):
As of December 31,
2021 2020
Cash and cash equivalents $ 1,375  $ 4,024 
Restricted cash —  501 
Total cash and restricted cash shown in the statements of cash flows $ 1,375  $ 4,525 
Schedule of Restricted Cash
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the balance sheets to the same amounts shown in the statement of cash flows as of December 31, 2021 and 2020 (in thousands):
As of December 31,
2021 2020
Cash and cash equivalents $ 1,375  $ 4,024 
Restricted cash —  501 
Total cash and restricted cash shown in the statements of cash flows $ 1,375  $ 4,525 
Revenue Product Sales by Channel
The following represents product sales by channel for food, drug and mass ("FDM"), natural product and other, and e-commerce for the years ended December 31, 2021 and 2020:
For the years ended December 31,
2021 2020
(in thousands) (in thousands)
Amount % of product sales, net Amount % of product sales, net
Retail - FDM $ 1,494  7.5  % $ 1,651  6.8  %
Retail - Natural products and other 11,054  55.1  % 15,073  61.7  %
E-Comm 7,500  37.4  % 7,705  31.5  %
Product sales, net $ 20,048  100.0  % $ 24,429  100.0  %